Hestia Insight Inc.

Equities

HSTA

US42815H1095

Diversified Investment Services

Market Closed - OTC Markets Other stock markets 10:47:36 2024-06-21 am EDT			5-day change	1st Jan Change
0.14 ^USD	+7.69%		-20.90%	-44.00%

Apr. 22	Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 29, 2024	CI
Mar. 14	Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2023	CI

Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2023

March 14, 2024 at 04:31 pm EDT

Hestia Insight Inc. reported earnings results for the full year ended November 30, 2023. For the full year, the company reported sales was USD 0.113413 million compared to USD 0.015 million a year ago. Revenue was USD 0.113413 million compared to USD 0.015 million a year ago.

Net loss was USD 0.500405 million compared to USD 1.71 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.06 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 0.06 a year ago.

Latest news about Hestia Insight Inc.

Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 29, 2024	Apr. 22	CI
Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2023	Mar. 14	CI
Hestia Insight Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	23-10-13	CI
Hestia Insight Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	23-07-14	CI
Hestia Insight Inc. entered into a Letter of Intent to acquire RecentCare Biomedical, Inc.	23-05-17	CI
Hestia Insight Inc. signed letter of intent to acquire Prisma Biotech Corporation .	23-05-09	CI
Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023	23-04-14	CI
Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2022	23-02-24	CI
Hestia Insight Inc. Auditor Raises 'Going Concern' Doubt	23-02-23	CI
Hestia Insight Inc. Appoints T.Z. Chaung as Advisory Board Member	23-01-05	CI
Hestia Insight Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022	22-10-17	CI
Hestia Insight Inc. Announces Advisory Board to Assist in Company Growth	22-07-28	CI
Hestia Insight Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022	22-07-14	CI
Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 28, 2022	22-04-13	CI
Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2021	22-02-25	CI
Hestia Insight Inc. Auditor Raises 'Going Concern' Doubt	22-02-24	CI
Hestia Insight Inc. Appoints Eugene Cha as Director of the Company	22-01-10	CI
Hestia Insight Inc. Enters into Memorandum of Understanding to Obtain Exclusive License to Brain Health and Functionality Technologies for the Treatment of Mental Health Conditions	21-12-29	CI
Hestia Insight Inc. Reports Earnings Results for the Third Quarter Ended August 31, 2021	21-10-12	CI
Hestia Insight Inc. Reports Earnings Results for the Second Quarter Ended May 31, 2021	21-07-06	CI
Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 28, 2021	21-04-19	CI
Hestia Insight Opens Two Offices, One in Taipei, the Other in Shanghai	20-05-26	CI
Hestia Insight Inc. will Change its Ticker to HSTA from LUXID	19-06-05	CI

Chart Hestia Insight Inc.

Duration

Period

More charts

Company Profile

Hestia Insight Inc. is focused primarily on the healthcare and biotech sectors through its two wholly owned subsidiaries, Hestia Investments Inc. (Hestia Investments), and HSTA HEALTH INC., doing business as Hestia Vending (Hestia Vending). Hestia Investments provides strategic consulting, medical supply sales and marketing support, management, and capital markets advisory services for select micro, small and medium sized companies within the healthcare and biotech sectors. Hestia Vending operates within the healthy food, beverage and wellness products industry and the smart vending machine industry. It makes strategic acquisitions of emerging growth companies with sciences and technologies. It also intends to pursue the acquisition and development of healthcare related technologies in the healthcare and biotech sectors through acquisition, licensing or joint ventures. It also provides sales and marketing guidance and services and capital markets advisory services to its clients.

Sector

Diversified Investment Services

More about the company

Income Statement Evolution

More financial data

Sector Diversified Investment Services

	1st Jan change	Capi.
HESTIA INSIGHT INC.	-44.00%	3.91M
MACQUARIE GROUP LIMITED	+8.39%	48.19B
EQUITABLE HOLDINGS, INC.	+23.48%	13.37B
SBI HOLDINGS, INC.	+22.95%	7.38B
VOYA FINANCIAL, INC.	-0.15%	7.34B
INVESTEC GROUP	+4.85%	6.54B
FIRST CAPITAL SECURITIES CO., LTD.	-9.29%	3.05B
AJ BELL PLC	+24.44%	2.03B
AMP LIMITED	+16.13%	1.87B
L1 LONG SHORT FUND LIMITED	+7.77%	1.32B

Diversified Investment Services